Primary Category:
Treatment Protocols
Disease Category:
Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic
Status:
Open
A Phase II Study of Sotorasib (AMG 510) in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
See Screening Protocol LUNGMAP
S1900E, Cohort 1 is closed to accrual effective December 13, 2023 at 12:00 p.m. PST.
LUNGMAP participants with KRASG12c and TP53 mutations and Wild Type STK11, KEAP1, NFE2L2, AND CUL3 will no longer be assigned to S1900E, effective December 13, 2023.
NCT#04625647
